Indications And Dose
SOMATULINE AUTOGEL ® Acromegaly (if somatostatin analogue not given previously) ▶BY DEEP SUBCUTANEOUS INJECTION ▶Adult: Initially 60 mg every 28 days, adjusted according Immune system and malignant disease to response, (consult product literature), for patients treated previously with somatostatin analogue, consult product literature for initial dose, dose to be given in the gluteal region Neuroendocrine (particularly carcinoid) tumours ▶BY DEEP SUBCUTANEOUS INJECTION ▶Adult: Initially 60–120 mg every 28 days, adjusted according to response, dose to be given in the gluteal region Unresectable locally advanced or metastatic gastroenteropancreatic neuroendocrine tumours of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded ▶BY DEEP SUBCUTANEOUS INJECTION ▶Adult: 120 mg every 28 days SOMATULINE LA ® Acromegaly and neuroendocrine (particularly carcinoid) tumours ▶BY INTRAMUSCULAR INJECTION ▶Adult: Initially 30 mg every 14 days, increased to 30 mg every 7–10 days, adjusted according to response Thyroid tumours ▶BY INTRAMUSCULAR INJECTION ▶Adult: Initially 30 mg every 14 days, increased to 30 mg every 10 days, adjusted according to response
PDF page 1023